Post-earnings recap
Reported
Mon, May 11, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a positive surprise on EPS, which contributed to a 3.17% increase in stock price. However, there was no revenue reported or guidance provided, leaving some uncertainty about future performance. Investors may view the EPS beat as a sign of resilience in the company's operations amid challenging conditions.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.03 | N/A | +125.00% |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, so the analysis is based solely on the numerical results.